New drug duo tested to shrink aggressive breast cancer before surgery
Disease control
Recruiting now
This study is testing whether a combination of two drugs, trastuzumab deruxtecan and durvalumab, can shrink tumors before surgery in people with stage III inflammatory breast cancer that expresses the HER2 protein. The goal is to see if this treatment can eliminate all detectable…
Phase: PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC